PRNewsWire
01 Sept 2026, 10:30 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
3 claims · each scored for market impact
Bio-Techne's greenhouse gas reduction targets, including a 70% reduction in Scope 1 and 2 emissions by fiscal year 2031, have been validated by the Science Based Targets initiative (SBTi). — ESG validation reduces regulatory risk and improves attractiveness to institutional funds, though it rarely drives short-term price volatility.
+0.10Bio-Techne has increased its total electricity consumption from renewable sources to 51%. — Operational efficiency and sustainability milestones are positive but have negligible immediate impact on financial performance.
+0.05The company has committed to ensuring 81% of its suppliers by spend have science-based targets by fiscal year 2030. — Supply chain sustainability efforts mitigate long-term systemic risk but do not alter current valuation.
+0.05Which stocks this story touches
Continue reading
6 related stories
Search tags
The company achieved science-based targets validation and reported significant progress toward its climate and sustainability goals.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
1h ago
